News
14h
Zacks.com on MSNBMY Stock Trades Near 52-Week Low: Time to Buy or Sell?BMY trims earnings outlook despite revenue beat and upbeat drug sales, sending shares to a 52-week low before a rebound. We ...
Further evidence that US Department of Health and Human Services (HHS) secretary Robert F Kennedy Junior (RFK Jr) is willing ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Global vaccine stocks traded lower on Wednesday after the U.S. Department of Health and Human Services announced it would ...
BioNTech also laid off 63 employees in June in conjunction with the discontinuation of its cell therapy manufacturing ...
Victoria is cementing its position as a global hub for biotechnology and life sciences, with BioNTech establishing a state-of ...
Summit Therapeutics Inc.'s valuation hinges on ivonescimab's potential, yet the data, competition, and regulatory issues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results